Combined therapy of iron chelator and antioxidant completely restores brain dysfunction induced by iron toxicity

PLoS One. 2014 Jan 6;9(1):e85115. doi: 10.1371/journal.pone.0085115. eCollection 2014.

Abstract

Background: Excessive iron accumulation leads to iron toxicity in the brain; however the underlying mechanism is unclear. We investigated the effects of iron overload induced by high iron-diet consumption on brain mitochondrial function, brain synaptic plasticity and learning and memory. Iron chelator (deferiprone) and antioxidant (n-acetyl cysteine) effects on iron-overload brains were also studied.

Methodology: Male Wistar rats were fed either normal diet or high iron-diet consumption for 12 weeks, after which rats in each diet group were treated with vehicle or deferiprone (50 mg/kg) or n-acetyl cysteine (100 mg/kg) or both for another 4 weeks. High iron-diet consumption caused brain iron accumulation, brain mitochondrial dysfunction, impaired brain synaptic plasticity and cognition, blood-brain-barrier breakdown, and brain apoptosis. Although both iron chelator and antioxidant attenuated these deleterious effects, combined therapy provided more robust results.

Conclusion: In conclusion, this is the first study demonstrating that combined iron chelator and anti-oxidant therapy completely restored brain function impaired by iron overload.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / administration & dosage*
  • Apoptosis
  • Blood-Brain Barrier / metabolism
  • Brain / drug effects
  • Brain / metabolism
  • Brain / pathology
  • Brain / physiopathology
  • Brain Diseases / drug therapy
  • Brain Diseases / etiology*
  • Brain Diseases / physiopathology*
  • Cognition
  • Diet / adverse effects
  • Disease Models, Animal
  • Drug Therapy, Combination
  • Iron / metabolism
  • Iron Chelating Agents / administration & dosage*
  • Iron Overload / complications*
  • Iron Overload / drug therapy*
  • Male
  • Maze Learning
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Mitochondria / pathology
  • Oxidative Stress
  • Rats
  • Treatment Outcome

Substances

  • Antioxidants
  • Iron Chelating Agents
  • Iron

Grants and funding

This work was supported by grants from the Thailand Research Fund TRF-BRG (SC), TRF-RTA5580006 (NC), Faculty of Medicine Chiang Mai University Endowment Fund (NC), National Research Council of Thailand (SC), Thailand Research Fund through the Royal Golden Jubilee Program (PHD/0248/2552: JS and SC), and Chiang Mai University Excellent Center Award (NC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.